Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells.

Himoudi N, Morgenstern DA, Yan M, Vernay B, Saraiva L, Wu Y, Cohen CJ, Gustafsson K, Anderson J.

J Immunol. 2012 Feb 15;188(4):1708-16. doi: 10.4049/jimmunol.1102654.

2.

Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens.

Kato Y, Tanaka Y, Hayashi M, Okawa K, Minato N.

J Immunol. 2006 Jul 15;177(2):877-84.

3.

Professional antigen-presentation function by human gammadelta T Cells.

Brandes M, Willimann K, Moser B.

Science. 2005 Jul 8;309(5732):264-8.

4.

Gammadelta T cells: an alternative type of professional APC.

Moser B, Brandes M.

Trends Immunol. 2006 Mar;27(3):112-8. Review.

PMID:
16442347
5.

Immunology. Now presenting: gammadelta T cells.

Modlin RL, Sieling PA.

Science. 2005 Jul 8;309(5732):252-3. No abstract available.

PMID:
16002604
8.

Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.

Kato Y, Tanaka Y, Tanaka H, Yamashita S, Minato N.

J Immunol. 2003 Apr 1;170(7):3608-13.

9.

Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.

Manches O, Plumas J, Lui G, Chaperot L, Molens JP, Sotto JJ, Bensa JC, Galili U.

Haematologica. 2005 May;90(5):625-34.

10.

Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses.

Brandes M, Willimann K, Bioley G, Lévy N, Eberl M, Luo M, Tampé R, Lévy F, Romero P, Moser B.

Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2307-12. doi: 10.1073/pnas.0810059106.

11.

Murine T cell determination of pregnancy outcome: I. Effects of strain, alphabeta T cell receptor, gammadelta T cell receptor, and gammadelta T cell subsets.

Arck PC, Ferrick DA, Steele-Norwood D, Croitoru K, Clark DA.

Am J Reprod Immunol. 1997 Jun;37(6):492-502. Erratum in: Am J Reprod Immunol 1997 Dec;38(6):438.

PMID:
9228307
12.

gammadelta T cells: novel initiators of adaptive immunity.

Moser B, Eberl M.

Immunol Rev. 2007 Feb;215:89-102. Review.

PMID:
17291281
13.

Tumor-activated TCRγδ⁺ T cells from gastric cancer patients induce the antitumor immune response of TCRαβ⁺ T cells via their antigen-presenting cell-like effects.

Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, Zheng T, Tong J, Wang S, Chen D.

J Immunol Res. 2014;2014:593562. doi: 10.1155/2014/593562.

14.

γδ T-APCs: a novel tool for immunotherapy?

Moser B, Eberl M.

Cell Mol Life Sci. 2011 Jul;68(14):2443-52. doi: 10.1007/s00018-011-0706-6. Review.

PMID:
21573785
16.

Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.

Muto M, Baghdadi M, Maekawa R, Wada H, Seino K.

Cancer Immunol Immunother. 2015 Aug;64(8):941-9. doi: 10.1007/s00262-015-1700-x.

PMID:
25904200
17.

Superantigen recognition by gammadelta T cells: SEA recognition site for human Vgamma2 T cell receptors.

Morita CT, Li H, Lamphear JG, Rich RR, Fraser JD, Mariuzza RA, Lee HK.

Immunity. 2001 Mar;14(3):331-44.

18.

Gamma delta T cells provide an early source of interferon gamma in tumor immunity.

Gao Y, Yang W, Pan M, Scully E, Girardi M, Augenlicht LH, Craft J, Yin Z.

J Exp Med. 2003 Aug 4;198(3):433-42.

19.

Gammadelta+ and CD4+ alphabeta+ human T cell subset responses upon stimulation with various Mycobacterium tuberculosis soluble extracts.

Batoni G, Esin S, Harris RA, Källenius G, Svenson SB, Andersson R, Campa M, Wigzell H.

Clin Exp Immunol. 1998 Apr;112(1):52-62.

20.

Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity.

Rischer M, Pscherer S, Duwe S, Vormoor J, Jürgens H, Rossig C.

Br J Haematol. 2004 Aug;126(4):583-92.

PMID:
15287953
Items per page

Supplemental Content

Support Center